Novo Nordisk, Ozempic Drugmaker, Sees Stock Plunge 20% After Profit Warning

Novo Nordisk slashed its financial forecasts as it struggled to fight off competition in the United States. It also named a new chief executive, who highlighted the “urgency” of the moment.